CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.68%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.74B
Cap. Flow
% of AUM
99.08%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$84.5M |
| 2 |
Gilead Sciences
GILD
|
+$83.7M |
| 3 |
Apple
AAPL
|
+$79.3M |
| 4 |
Qualcomm
QCOM
|
+$74.7M |
| 5 |
Amgen
AMGN
|
+$73M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.71% |
| 4 | Industrials | 8% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
American Tower
AMT
$91.2B
| $2.43M | 0.05% |
+24,593
| New | +$2.43M |
|
327
Enbridge
ENB
$106B
| $2.38M | 0.05% |
+46,155
| New | +$2.38M |
|
|
SAGE
328
DELISTED
Sage Therapeutics
SAGE
| $2.38M | 0.05% |
+65,000
| New | +$2.38M |
|
329
Booking.com
BKNG
$177B
| $2.37M | 0.05% |
+2,076
| New | +$2.37M |
|
330
Simon Property Group
SPG
$58.3B
| $2.35M | 0.05% |
+12,895
| New | +$2.35M |
|
331
Zoetis
ZTS
$66.3B
| $2.34M | 0.05% |
+54,466
| New | +$2.34M |
|
|
KTWO
332
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.3M | 0.05% |
+110,000
| New | +$2.3M |
|
333
Scotiabank
BNS
$79.2B
| $2.29M | 0.05% |
+42,327
| New | +$2.29M |
|
|
TLM
334
DELISTED
TALISMAN ENERGY INC
TLM
| $2.29M | 0.05% |
+290,901
| New | +$2.29M |
|
|
SGEN
335
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.25M | 0.05% |
+70,000
| New | +$2.25M |
|
|
WBA
336
DELISTED
Walgreens Boots Alliance
WBA
| $2.25M | 0.05% |
+29,505
| New | +$2.25M |
|
337
Esperion Therapeutics
ESPR
$508M
| $2.22M | 0.05% |
+55,000
| New | +$2.22M |
|
338
Morgan Stanley
MS
$246B
| $2.2M | 0.05% |
+56,728
| New | +$2.2M |
|
|
TTPH
339
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.18M | 0.05% |
+2,750
| New | +$2.18M |
|
340
Geron
GERN
$829M
| $2.18M | 0.05% |
+670,000
| New | +$2.18M |
|
|
XLRN
341
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.14M | 0.04% |
+55,000
| New | +$2.14M |
|
342
Range Resources
RRC
$8.25B
| $2.11M | 0.04% |
+39,465
| New | +$2.11M |
|
|
MDCO
343
DELISTED
Medicines Co
MDCO
| $2.08M | 0.04% |
+75,000
| New | +$2.08M |
|
344
Costco
COST
$425B
| $2M | 0.04% |
+14,085
| New | +$2M |
|
345
Kinder Morgan
KMI
$60.3B
| $1.99M | 0.04% |
+47,009
| New | +$1.99M |
|
|
OMED
346
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.96M | 0.04% |
+90,000
| New | +$1.96M |
|
347
Align Technology
ALGN
$9.73B
| $1.96M | 0.04% |
+35,000
| New | +$1.96M |
|
|
BDSI
348
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.92M | 0.04% |
+160,000
| New | +$1.92M |
|
349
MEI Pharma
MEIP
$105M
| $1.91M | 0.04% |
+22,365
| New | +$1.91M |
|
350
CMS Energy
CMS
$21.2B
| $1.91M | 0.04% |
+54,878
| New | +$1.91M |
|